22nd Century Group Announces Conference Call to Provide Business Update
WILLIAMSVILLE, N.Y.–(BUSINESS WIRE)–22nd Century Group, Inc. (NYSE American: XXII), a plant biotechnology company that is a leader in tobacco harm…
Pharmaceuticals, Biotechnology and Life Sciences
WILLIAMSVILLE, N.Y.–(BUSINESS WIRE)–22nd Century Group, Inc. (NYSE American: XXII), a plant biotechnology company that is a leader in tobacco harm…
DUBLIN–(BUSINESS WIRE)–The “Global Compounding Pharmacies Market: Analysis By Product Type, By Therapeutic Area, End User, By Region, By Country (2019…
Registration Study for Mirvetuximab Soravtansine in Ovarian Cancer on Track to Start by Year-End Full Data from the Phase 3…
LONDON–(BUSINESS WIRE)–#Biotechnology–The global esoteric testing market is expected to grow by USD 14.53 billion by 2023, according to the latest…
DUBLIN–(BUSINESS WIRE)–The “Global Orphan Drugs Market – Growth, Trends and Forecasts 2019 – 2024” report has been added to ResearchAndMarkets.com’s…
STRASBOURG, France–(BUSINESS WIRE)–#Transgene–Regulatory News: Transgene (Paris:TNG), a biotech company designing and developing virus-based immunotherapies for the treatment of solid tumors,…
STEVENAGE, England–(BUSINESS WIRE)–#Antikor–Biotechnology company Antikor Biopharma Ltd is pleased to announce that it has entered into an Investment Agreement for…
– Received EU conditional marketing authorization for ZYNTEGLO® (autologous CD34+ cells encoding βA-T87Q-globin gene) gene therapy for patients 12 years…
HERCULES, Calif.–(BUSINESS WIRE)–Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products,…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Dicerna™ Pharmaceuticals, Inc. (Nasdaq: DRNA) (the “Company” or “Dicerna”), a leading developer of investigational ribonucleic acid interference (RNAi)…